Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Optum and Avalon Discuss Genetic Test Claims Review

One goal is to lessen prior authorization burdens through greater specificity about test validity, utility

CEO SUMMARY: With the ever-increasing number of genetic tests on the market, payers are understandably frustrated with genetic test claims that don’t clearly outline the medical need for a procedure or its clinical validity. One path forward is for labs to present data to justify a genetic test earlier in processing of the claim. GENETIC …

Optum and Avalon Discuss Genetic Test Claims Review Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.